Kirsten A. Porter‐Stransky

This study develops a transgenic mouse model expressing human alpha-synuclein in noradrenergic neurons, revealing LC pathology and non-motor PD features.

This study shows that loss of β-arrestin2 in D2 neurons reduces dopamine inhibition of D2-MSNs and alters behavioral responses to psychostimulants and opioids, while having minimal effect on D1 neurons.

This study compares the effects of selective D2 and D3 receptor antagonists on cocaine-induced behaviors in mice, finding opposite modulatory effects on locomotor activity and dopamine signaling.

The paper develops a system to measure opioid peptide release in vivo using optogenetics, microdialysis, and mass spectrometry in freely moving rodents.